I fully expect we will have one more dilution round as Harvey is firmly committed to make this a standalone oncology company..
My hope of hope is that Rida is successful, and the resultant cash flow from Merck on approval of Rida will allow Ariad to issue some debt, and leave us shareholders alone for awhile.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.